/ Not yet recruitingNot Applicable [Translation] Bioequivalence study of indobufen tablets in humans
比较空腹及餐后给药条件下,山东鲁盛制药有限公司生产的吲哚布芬片(规格:0.2g)与 Pfizer Italia S.r.l. 持证及生产的吲哚布芬片(规格:0.2g,商品名:Ibustrin ®)在健康人群中吸收程度和速度的差异。评价两制剂的安全性和耐受性,为该受试制剂注册申请提供依据。
[Translation] To compare the differences in the extent and rate of absorption of indobufen tablets (specification: 0.2g) produced by Shandong Lusheng Pharmaceutical Co., Ltd. and indobufen tablets (specification: 0.2g, trade name: Ibustrin ®) licensed and produced by Pfizer Italia S.r.l. in healthy people under fasting and postprandial administration conditions. To evaluate the safety and tolerability of the two preparations and provide a basis for the registration application of the test preparation.
100 Clinical Results associated with Shandong Lusheng Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shandong Lusheng Pharmaceutical Co., Ltd.
100 Deals associated with Shandong Lusheng Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shandong Lusheng Pharmaceutical Co., Ltd.